Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: The NIA-AA proposed amyloid-tau-neurodegeneration (ATN) as a classification system for AD biomarkers. The amyloid cascade hypothesis (ACH) implies a sequence across ATN groups that patients might undergo during transition from healthy towards AD: A-T-N-➔A+T-N-➔A+T+N-➔A+T+N+. Here we assess the evidence for monotonic brain volume decline for this particular (amyloid-conversion first, tau-conversion second, N-conversion last) and alternative progressions using voxel-based morphometry (VBM) in a large cross-sectional MRI cohort.

Methods: We used baseline data of the DELCODE cohort of 437 subjects (127 controls, 168 SCD, 87 MCI, 55 AD patients) which underwent lumbar puncture, MRI scanning, and neuropsychological assessment. ATN classification was performed using CSF-Aβ42/Aβ40 (A+/-), CSF phospho-tau (T+/-), and adjusted hippocampal volume or CSF total-tau (N+/-). We compared voxel-wise model evidence for monotonic decline of gray matter volume across various sequences over ATN groups using the Bayesian Information Criterion (including also ROIs of Braak stages). First, face validity of the ACH transition sequence A-T-N-➔A+T-N-➔A+T+N-➔A+T+N+ was compared against biologically less plausible (permuted) sequences among AD continuum ATN groups. Second, we evaluated evidence for 6 monotonic brain volume progressions from A-T-N- towards A+T+N+ including also non-AD continuum ATN groups.

Results: The ACH-based progression A-T-N-➔A+T-N-➔A+T+N-➔A+T+N+ was consistent with cognitive decline and clinical diagnosis. Using hippocampal volume for operationalization of neurodegeneration (N), ACH was most evident in 9% of gray matter predominantly in the medial temporal lobe. Many cortical regions suggested alternative non-monotonic volume progressions over ACH progression groups, which is compatible with an early amyloid-related tissue expansion or sampling effects, e.g., due to brain reserve. Volume decline in 65% of gray matter was consistent with a progression where A status converts before T or N status (i.e., ACH/ANT) when compared to alternative sequences (TAN/TNA/NAT/NTA). Brain regions earlier affected by tau tangle deposition (Braak stage I-IV, MTL, limbic system) present stronger evidence for volume decline than late Braak stage ROIs (V/VI, cortical regions). Similar findings were observed when using CSF total-tau for N instead.

Conclusion: Using the ATN classification system, early amyloid status conversion (before tau and neurodegeneration) is associated with brain volume loss observed during AD progression. The ATN system and the ACH are compatible with monotonic progression of MTL atrophy.

Trial Registration: DRKS00007966, 04/05/2015, retrospectively registered.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10009950PMC
http://dx.doi.org/10.1186/s13195-023-01185-xDOI Listing

Publication Analysis

Top Keywords

atn classification
16
classification system
12
atn groups
12
evidence monotonic
12
brain volume
12
volume decline
12
gray matter
12
volume
9
atn
8
monotonic brain
8

Similar Publications

Introduction: We investigated associations of plasma proteins with blood-based amyloid/tau/neurodegeneration/inflammation (A/T/N/I) biomarkers for Alzheimer's disease (AD).

Methods: Plasma proteomics and clinical data from the Indiana AD Research Center (N = 498) were used. Association analysis of plasma proteins with blood A/T/N/I biomarkers as well as diagnosis was performed, followed by replication in an independent cohort (N = 323), network analysis, pathway enrichment, and machine learning classification to identify proteins and pathways related to AD risk.

View Article and Find Full Text PDF

The Cicadellinae subfamily of the Cicadellidae (Hemiptera: Auchenorrhyncha: Cicadelloidea) is quite large, with about 2400 species across 330 genera worldwide, of which 263 species in 23 genera occur in China. This work involved the sequencing of the mitochondrial genomes of ten species and nine genera within the Cicadellinae family: Anagonalia emeiensis, Anagonalia melichari, Anatkina vespertinula, Erragonalia choui, Gunungidia aurantiifasciata, Kolla paulula, Nanatka castenea, Paratkina nigrifasciana, Seasogonia rosea, and Stenatkina angustata. The acquired mitogenomes displays a significant AT bias, with the AT contents ranging from 76.

View Article and Find Full Text PDF

miR-423-5p and miR-92a-3p in Alzheimer's disease: relationship with pathology and cognition.

Front Aging Neurosci

July 2025

Department of Radiology and Imaging Sciences, Center for Computational Biology and Bioinformatics, Indiana Alzheimer's Disease Research Center, Indiana University School of Medicine, Indianapolis, IN, United States.

Background: MicroRNAs (miRNAs), small and highly conserved non-coding RNA molecules, have emerged as promising molecular biomarkers due to their regulatory roles in gene expression and stability in blood.

Methods: We used measurements of 64 plasma miRNAs from 145 participants in the Alzheimer's disease Neuroimaging Initiative cohort, including 74 probable AD patients and 71 cognitively normal (CN) older adults. We performed principal component analysis (PCA) with factor rotation for dimension reduction to identify AD-associated principal components (PCs) and their key miRNAs with factor loadings higher than 0.

View Article and Find Full Text PDF

Background: Accurate quantification of the extent of bronchial damage across various airway levels in chronic obstructive pulmonary disease (COPD) remains a challenge. In this study, artificial intelligence (AI) was employed to develop an airway segmentation model to investigate the morphological changes of the central and peripheral airways in COPD patients and the effects of these airway changes on pulmonary function classification and acute COPD exacerbations.

Methods: Clinical data from a total of 340 patients with COPD and 73 healthy volunteers were collected and compiled.

View Article and Find Full Text PDF

Introduction: Using the ATN framework, we evaluated the potential of plasma biomarkers to identify abnormal brain amyloid-beta (Aβ) positron emission tomography (PET), tau-PET and neurodegeneration in a socioeconomically disadvantaged population-based cohort.

Methods: Community-dwelling dementia-free (n = 113, including 102 (91%) cognitively normal) participants underwent ATN neuroimaging and plasma biomarker assessments.

Results: Plasma Aβ42/Aβ40, p-tau181, and p-tau217 showed significant associations with Aβ-PET status, (adjusted odds ratio [AOR] of 1.

View Article and Find Full Text PDF